Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-010200
Filing Date
2025-01-29
Accepted
2025-01-29 07:00:03
Documents
1
Period of Report
2025-01-29

Document Format Files

Seq Description Document Type Size
1 6-K workforce_reduction_1.28.htm 6-K 23911
  Complete submission text file 0000950170-25-010200.txt   24936
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 25566640
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)